Patrick Wood
Stock Analyst at Morgan Stanley
(2.94)
# 1,633
Out of 5,006 analysts
105
Total ratings
46.15%
Success rate
0.78%
Average return
Main Sectors:
Stocks Rated by Patrick Wood
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| COO The Cooper Companies | Maintains: Equal-Weight | $84 → $76 | $70.11 | +8.40% | 6 | Aug 28, 2025 | |
| ALC Alcon | Maintains: Equal-Weight | $84 → $80 | $76.82 | +4.14% | 5 | Aug 21, 2025 | |
| BDX Becton, Dickinson and Company | Maintains: Overweight | $196 → $197 | $191.99 | +2.61% | 5 | Aug 11, 2025 | |
| STE STERIS | Maintains: Overweight | $276 → $295 | $240.64 | +22.59% | 7 | Aug 8, 2025 | |
| TMDX TransMedics Group | Maintains: Equal-Weight | $115 → $123 | $113.93 | +7.96% | 2 | Aug 1, 2025 | |
| BLCO Bausch + Lomb | Maintains: Equal-Weight | $12 → $13 | $14.89 | -12.69% | 8 | Aug 1, 2025 | |
| GEHC GE HealthCare Technologies | Maintains: Equal-Weight | $78 → $74 | $76.41 | -3.15% | 7 | Jul 31, 2025 | |
| PRCT PROCEPT BioRobotics | Maintains: Overweight | $71 → $68 | $35.24 | +92.96% | 3 | Jul 15, 2025 | |
| EW Edwards Lifesciences | Maintains: Equal-Weight | $75 → $81 | $76.56 | +5.80% | 9 | Jul 15, 2025 | |
| DXCM DexCom | Maintains: Equal-Weight | $82 → $89 | $66.36 | +34.12% | 8 | Jul 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $28 → $27 | $23.15 | +16.63% | 5 | Jul 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $20 → $9 | $8.49 | +6.01% | 2 | Jul 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $80 → $103 | $73.78 | +39.60% | 5 | Jul 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $120 → $125 | $96.70 | +29.27% | 6 | May 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $110 → $72 | $86.62 | -16.88% | 4 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $191 → $173 | $127.71 | +35.46% | 5 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $45 → $22 | $15.01 | +46.57% | 4 | Mar 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $234 → $317 | $311.69 | +1.70% | 5 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $18 → $10 | $6.91 | +44.72% | 2 | Jul 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $50 → $37 | $26.83 | +37.91% | 2 | Jul 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $128.14 | - | 5 | Dec 11, 2017 |
The Cooper Companies
Aug 28, 2025
Maintains: Equal-Weight
Price Target: $84 → $76
Current: $70.11
Upside: +8.40%
Alcon
Aug 21, 2025
Maintains: Equal-Weight
Price Target: $84 → $80
Current: $76.82
Upside: +4.14%
Becton, Dickinson and Company
Aug 11, 2025
Maintains: Overweight
Price Target: $196 → $197
Current: $191.99
Upside: +2.61%
STERIS
Aug 8, 2025
Maintains: Overweight
Price Target: $276 → $295
Current: $240.64
Upside: +22.59%
TransMedics Group
Aug 1, 2025
Maintains: Equal-Weight
Price Target: $115 → $123
Current: $113.93
Upside: +7.96%
Bausch + Lomb
Aug 1, 2025
Maintains: Equal-Weight
Price Target: $12 → $13
Current: $14.89
Upside: -12.69%
GE HealthCare Technologies
Jul 31, 2025
Maintains: Equal-Weight
Price Target: $78 → $74
Current: $76.41
Upside: -3.15%
PROCEPT BioRobotics
Jul 15, 2025
Maintains: Overweight
Price Target: $71 → $68
Current: $35.24
Upside: +92.96%
Edwards Lifesciences
Jul 15, 2025
Maintains: Equal-Weight
Price Target: $75 → $81
Current: $76.56
Upside: +5.80%
DexCom
Jul 15, 2025
Maintains: Equal-Weight
Price Target: $82 → $89
Current: $66.36
Upside: +34.12%
Jul 15, 2025
Maintains: Underweight
Price Target: $28 → $27
Current: $23.15
Upside: +16.63%
Jul 15, 2025
Downgrades: Equal-Weight
Price Target: $20 → $9
Current: $8.49
Upside: +6.01%
Jul 15, 2025
Upgrades: Overweight
Price Target: $80 → $103
Current: $73.78
Upside: +39.60%
May 16, 2025
Maintains: Overweight
Price Target: $120 → $125
Current: $96.70
Upside: +29.27%
May 6, 2025
Maintains: Underweight
Price Target: $110 → $72
Current: $86.62
Upside: -16.88%
May 5, 2025
Maintains: Overweight
Price Target: $191 → $173
Current: $127.71
Upside: +35.46%
Mar 5, 2025
Downgrades: Equal-Weight
Price Target: $45 → $22
Current: $15.01
Upside: +46.57%
Nov 11, 2024
Maintains: Overweight
Price Target: $234 → $317
Current: $311.69
Upside: +1.70%
Jul 15, 2024
Maintains: Equal-Weight
Price Target: $18 → $10
Current: $6.91
Upside: +44.72%
Jul 15, 2024
Downgrades: Underweight
Price Target: $50 → $37
Current: $26.83
Upside: +37.91%
Dec 11, 2017
Upgrades: Buy
Price Target: n/a
Current: $128.14
Upside: -